143 related articles for article (PubMed ID: 8839832)
1. A variant CD30 protein lacking extracellular and transmembrane domains is induced in HL-60 by tetradecanoylphorbol acetate and is expressed in alveolar macrophages.
Horie R; Ito K; Tatewaki M; Nagai M; Aizawa S; Higashihara M; Ishida T; Inoue J; Takizawa H; Watanabe T
Blood; 1996 Oct; 88(7):2422-32. PubMed ID: 8839832
[TBL] [Abstract][Full Text] [Related]
2. Frequent expression of the variant CD30 in human malignant myeloid and lymphoid neoplasms.
Horie R; Gattei V; Ito K; Imajo-Ohmi S; Tange T; Miyauchi J; Pinto A; Degan M; De Iuliis A; Tassan Mazzocco F; Rossi FM; Higashihara M; Watanabe T
Am J Pathol; 1999 Dec; 155(6):2029-41. PubMed ID: 10595933
[TBL] [Abstract][Full Text] [Related]
3. Cloning and characterization of a cDNA for rat CD30 homolog and chromosomal assignment of the genomic gene.
Aizawa S; Satoh H; Horie R; Ito K; Choi SH; Takeuchi H; Watanabe T
Gene; 1996 Dec; 182(1-2):155-62. PubMed ID: 8982082
[TBL] [Abstract][Full Text] [Related]
4. 12-O-tetradecanoylphorbol-13-acetate (TPA) downregulates expression of CD30 in erythroleukemia cell line K562.
Ezawa H; Harigaya K; Ishii G; Nakajima N; Mikata A
Hematol Oncol; 1997 Aug; 15(3):151-61. PubMed ID: 9600114
[TBL] [Abstract][Full Text] [Related]
5. Expression of the apolipoprotein C-II gene during myelomonocytic differentiation of human leukemic cells.
Chun EM; Park YJ; Kang HS; Cho HM; Jun DY; Kim YH
J Leukoc Biol; 2001 Apr; 69(4):645-50. PubMed ID: 11310852
[TBL] [Abstract][Full Text] [Related]
6. Id2 expression increases with differentiation of human myeloid cells.
Ishiguro A; Spirin KS; Shiohara M; Tobler A; Gombart AF; Israel MA; Norton JD; Koeffler HP
Blood; 1996 Jun; 87(12):5225-31. PubMed ID: 8652837
[TBL] [Abstract][Full Text] [Related]
7. A novel transcript encoded within the 10-kb first intron of the human p53 tumor suppressor gene (D17S2179E) is induced during differentiation of myeloid leukemia cells.
Reisman D; Bálint é ; Loging WT; Rotter V; Almon E
Genomics; 1996 Dec; 38(3):364-70. PubMed ID: 8975713
[TBL] [Abstract][Full Text] [Related]
8. Modulation of homeobox B6 and B9 genes expression in human leukemia cell lines during myelomonocytic differentiation.
Ohnishi K; Tobita T; Sinjo K; Takeshita A; Ohno R
Leuk Lymphoma; 1998 Nov; 31(5-6):599-608. PubMed ID: 9922051
[TBL] [Abstract][Full Text] [Related]
9. Distinct temporal patterns of defensin mRNA regulation during drug-induced differentiation of human myeloid leukemia cells.
Herwig S; Su Q; Zhang W; Ma Y; Tempst P
Blood; 1996 Jan; 87(1):350-64. PubMed ID: 8547662
[TBL] [Abstract][Full Text] [Related]
10. TRAF2 recruitment via T61 in CD30 drives NFκB activation and enhances hESC survival and proliferation.
Thakar NY; Ovchinnikov DA; Hastie ML; Kobe B; Gorman JJ; Wolvetang EJ
Mol Biol Cell; 2015 Mar; 26(5):993-1006. PubMed ID: 25568342
[TBL] [Abstract][Full Text] [Related]
11. Phorbol ester-stimulated phosphorylation of PU.1: association with leukemic cell growth inhibition.
Carey JO; Posekany KJ; deVente JE; Pettit GR; Ways DK
Blood; 1996 May; 87(10):4316-24. PubMed ID: 8639791
[TBL] [Abstract][Full Text] [Related]
12. Activation of Hodgkin cells via the CD30 receptor induces autocrine secretion of interleukin-6 engaging the NF-kappabeta transcription factor.
Gruss HJ; Ulrich D; Dower SK; Herrmann F; Brach MA
Blood; 1996 Mar; 87(6):2443-9. PubMed ID: 8630409
[TBL] [Abstract][Full Text] [Related]
13. Genomic structure, chromosomal localization and expression profile of a novel melanoma differentiation associated (mda-7) gene with cancer specific growth suppressing and apoptosis inducing properties.
Huang EY; Madireddi MT; Gopalkrishnan RV; Leszczyniecka M; Su Z; Lebedeva IV; Kang D; Jiang H; Lin JJ; Alexandre D; Chen Y; Vozhilla N; Mei MX; Christiansen KA; Sivo F; Goldstein NI; Mhashilkar AB; Chada S; Huberman E; Pestka S; Fisher PB
Oncogene; 2001 Oct; 20(48):7051-63. PubMed ID: 11704829
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of TPA-induced growth inhibition and apoptosis in myeloid leukemia cells by BAY 11-7082, an NF-kappaB inhibitor.
Hansson A; Marín YE; Suh J; Rabson AB; Chen S; Huberman E; Chang RL; Conney AH; Zheng X
Int J Oncol; 2005 Oct; 27(4):941-8. PubMed ID: 16142309
[TBL] [Abstract][Full Text] [Related]
15. Distinct motifs in the intracellular domain of human CD30 differentially activate canonical and alternative transcription factor NF-κB signaling.
Buchan SL; Al-Shamkhani A
PLoS One; 2012; 7(9):e45244. PubMed ID: 23028875
[TBL] [Abstract][Full Text] [Related]
16. Novel vitamin D(3) analog, 21-(3-methyl-3-hydroxy-butyl)-19-nor D(3), that modulates cell growth, differentiation, apoptosis, cell cycle, and induction of PTEN in leukemic cells.
Hisatake J; O'Kelly J; Uskokovic MR; Tomoyasu S; Koeffler HP
Blood; 2001 Apr; 97(8):2427-33. PubMed ID: 11290607
[TBL] [Abstract][Full Text] [Related]
17. A novel, myeloid transcription factor, C/EBP epsilon, is upregulated during granulocytic, but not monocytic, differentiation.
Morosetti R; Park DJ; Chumakov AM; Grillier I; Shiohara M; Gombart AF; Nakamaki T; Weinberg K; Koeffler HP
Blood; 1997 Oct; 90(7):2591-600. PubMed ID: 9326225
[TBL] [Abstract][Full Text] [Related]
18. Selective use of an alternative stop codon and polyadenylation signal within intron sequences leads to a truncated topoisomerase II alpha messenger RNA and protein in human HL-60 leukemia cells selected for resistance to mitoxantrone.
Harker WG; Slade DL; Parr RL; Holguin MH
Cancer Res; 1995 Nov; 55(21):4962-71. PubMed ID: 7585537
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor receptor-associated factor (TRAF)-1, TRAF-2, and TRAF-3 interact in vivo with the CD30 cytoplasmic domain; TRAF-2 mediates CD30-induced nuclear factor kappa B activation.
Ansieau S; Scheffrahn I; Mosialos G; Brand H; Duyster J; Kaye K; Harada J; Dougall B; Hübinger G; Kieff E; Herrmann F; Leutz A; Gruss HJ
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14053-8. PubMed ID: 8943059
[TBL] [Abstract][Full Text] [Related]
20. Cloning and characterization of three isoforms of OS-9 cDNA and expression of the OS-9 gene in various human tumor cell lines.
Kimura Y; Nakazawa M; Yamada M
J Biochem; 1998 May; 123(5):876-82. PubMed ID: 9562620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
